#this is a broad statement directed at multiple tumblr users

[zombiesama]

IDK something about posting a collection of random unsourced buttons/other web graphics and adding a ko-fi link in the post just feels like super rude.

A lot of button makers are very aware that their art is almost guaranteed to be stolen and posted without credit (some are ok with that, others are not) which is bad/annoying enough, but asking for money? on a post of a bunch of other starving artists' art?

How dare you, honestly!

What did you contribute to deserve money? All you did was download some images.

[diarrheaworldstarhiphop]

Russian efforts to meddle in American politics did not end at Facebook and Twitter. A CNN investigation of a Russian-linked account shows its tentacles extended to YouTube, Tumblr and even Pokémon Go.

PRATE NOTE: THE ABSOLUTE STATE OF THE RUSSIAN FEARMONGERING IN AMERICAN MEDIA

------------------------

One Russian-linked campaign posing as part of the Black Lives Matter movement used Facebook, Instagram, Twitter, YouTube, Tumblr and Pokémon Go and even contacted some reporters in an effort to exploit racial tensions and sow discord among Americans, CNN has learned.

The campaign, titled "Don't Shoot Us," offers new insights into how Russian agents created a broad online ecosystem where divisive political messages were reinforced across multiple platforms, amplifying a campaign that appears to have been run from one source -- the shadowy, Kremlin-linked troll farm known as the Internet Research Agency.

A source familiar with the matter confirmed to CNN that the Don't Shoot Us Facebook page was one of the 470 accounts taken down after the company determined they were linked to the IRA. CNN has separately established the links between the Facebook page and the other Don't Shoot Us accounts.

The Don't Shoot Us campaign -- the title of which may have referenced the "Hands Up, Don't Shoot" slogan that became popular in the wake of the shooting of Michael Brown -- used these platforms to highlight incidents of alleged police brutality, with what may have been the dual goal of galvanizing African Americans to protest and encouraging other Americans to view black activism as a rising threat.

The Facebook, Instagram and Twitter accounts belonging to the campaign are currently suspended. The group's YouTube channel and website were both still active as of Thursday morning. The Tumblr page now posts about Palestine.

Related: Exclusive: Russian-linked group sold merchandise online

All of the aforementioned companies declined to comment on the Don't Shoot Us campaign. Representatives from Facebook, Twitter and Alphabet, the parent company of Google and YouTube, have agreed to testify before the Senate and House Intelligence Committees on November 1, according to sources at all three companies

Tracing the links between the various Don't Shoot Us social media accounts shows how one YouTube video or Twitter post could lead users down a rabbit hole of activist messaging and ultimately encourage them to take action.

The Don't Shoot Us YouTube page, which is simply titled "Don't Shoot," contains more than 200 videos of news reports, police surveillance tape and amateur footage showing incidents of alleged police brutality. These videos, which were posted between May and December of 2016, have been viewed more than 368,000 times.

All of these YouTube videos link back to a donotshoot.us website. This website was registered in March 2016 to a "Clerk York" in Illinois. Public records do not show any evidence that someone named Clerk York lives in Illinois. The street address and phone number listed in the website's registration belong to a shopping mall in North Riverside, Illinois.

The donotshoot.us website in turn links to a Tumblr account. In July 2016, this Tumblr account announced a contest encouraging readers to play Pokémon Go, the augmented reality game in which users go out into the real world and use their phones to find and "train" Pokémon characters.

Specifically, the Don't Shoot Us contest directed readers to go to find and train Pokémon near locations where alleged incidents of police brutality had taken place. Users were instructed to give their Pokémon names corresponding with those of the victims. A post promoting the contest showed a Pokémon named "Eric Garner," for the African-American man who died after being put in a chokehold by a New York Police Department officer.

Winners of the contest would receive Amazon gift cards, the announcement said.

It's unclear what the people behind the contest hoped to accomplish, though it may have been to remind people living near places where these incidents had taken place of what had happened and to upset or anger them.

CNN has not found any evidence that any Pokémon Go users attempted to enter the contest, or whether any of the Amazon Gift Cards that were promised were ever awarded -- or, indeed, whether the people who designed the contest ever had any intention of awarding the prizes.

"It's clear from the images shared with us by CNN that our game assets were appropriated and misused in promotions by third parties without our permission," Niantic, the makers of Pokémon Go, said in a statement provided to CNN.

"It is important to note that Pokémon GO, as a platform, was not and cannot be used to share information between users in the app so our platform was in no way being used. This 'contest' required people to take screen shots from their phone and share over other social networks, not within our game. Niantic will consider our response as we learn more."

The Tumblr page that promoted the contest no longer posts about U.S. police violence. It now appears to be devoted pro-Palestine campaigns.

Tumblr would not confirm to CNN if the same people who operated the Tumblr page about Black Lives Matter now operate the pro-Palestinian page, citing the company's privacy policy. Tumblr also would not say whether it is investigating potential Russian use of its platform before, during or after the 2016 presidential election.

Related: Facebook could still be weaponized again for the 2018 midterms

Don't Shoot Us also worked to spread its influence beyond the digital world.

It used Facebook -- on which it had more than 254,000 likes as of September 2016 -- to publicize at least one real-world event designed to appear to be part of the Black Lives Matter Movement.

Just a day after the shooting of Philando Castile by police in a suburb of Saint Paul, Minnesota in July 2016, local activists in Minnesota noticed a Facebook event for a protest being shared by a group they didn't recognize.

Don't Shoot Us was publicizing a protest outside the St. Anthony Police Department, where Jeronimo Yanez, the officer who shot Castile, worked. Local activists had been protesting outside the Minnesota Governor's Mansion.

When an activist group with ties to a local union reached out to the page, someone with Don't Shoot Us replied and explained that they were not in Minnesota but planned to open a "chapter" in the state in the following months.

The local group became more suspicious. After investigating further, including finding the website registration information showing a mall address, they posted on their website to say that Don't Shoot Us was a "total troll job."

CNN has reached out to those local activists but had not heard back as of the time of this article's publication.

Brandon Long, the state party chairman of the Green Party of Minnesota, remembers hearing about the planned Don't Shoot Us event. He told CNN, "We frequently support Black Lives Matter protests and demonstrations and we know pretty much all the organizers in town and that page wasn't recognized by anyone."

This was not the only event that Don't Shoot Us worked to promote.

In June 2016, someone using the Gmail address that had been posted as part of the Pokémon Go contest promotion reached out to Brandon Weigel, an editor at Baltimore City Paper, to promote a protest at a courthouse where one of the officers involved in the arrest of Freddie Gray was due to appear.

The email made Weigel suspicious. "City Paper editors and reporters are familiar with many of the activist groups doing work in Baltimore, so it was strange to receive an email from an outside group trying to start a protest outside the courthouse," Weigel told CNN.

Weigel wasn't the only reporter to be on the receiving end of communications from Don't Shoot Us. Last January, someone named Daniel Reed, who was described as the "Chief Editor" of DoNotShoot.Us, gave an interview to a contributor at the now defunct International Press Foundation (IPF), a website where students and trainee journalists regularly posted articles.

"There is no civilised country in the world that suffers so many cases of police brutality against civilians," IPF quoted "Reed" as saying, among other things. (IPF was responsible for the British spelling of "civilised.")

The IPF contributor confirmed to CNN that the interview occurred through email and that she never spoke to "Reed" on the phone. The email address that "Reed" used for the interview was the same one that reached out to Weigel in Baltimore and that was included in the promotion for the Pokémon Go contest.

"Reed" sent the answers to IPF's questions in a four-page Microsoft Word document. The document, which outlined what "Reed" described as problems with the American justice system and police brutality, was written entirely in English.

However, when CNN examined the document metadata, "Название," the Russian word for "name," was part of the document properties.

Two cybersecurity experts who reviewed the document's metadata told CNN that it was likely created on a computer or a program running Russian as its primary language.

To date, Facebook has said that it identified 470 accounts linked to the Internet Research Agency, while Twitter has identified 201 accounts. Google has not released its findings, though CNN has confirmed that the company has identified tens of thousands of dollars spent on ad buys by Russian accounts.

Facebook and Twitter have submitted detailed records of their findings to both Congress and the office of Special Counsel Robert Mueller, who is conducting an investigation into Russian meddling in the 2016 presidential campaign.

On Friday, Maria Zakharova, the spokeswoman for the Russian Foreign Ministry, made her displeasure with this story clear in a Facebook post written in Russian, calling CNN a "talentless television channel" and saying,"Again the Russians are to blame... and the Pokémons they control."

-- CNN's Jose Pagliery and Tal Yellin contributed reporting.

Fcuking hilarioooouss

MEDIA E D I A

ok, lets break it down:

1. the sustained russia narrative serves the purpose of preventing the left wing in America to have a moment of self-reflection WRT the corruption and plutocracy inherent within the Democrat Party after the complete collapse of Hillary’s Presidential bid. The Democrats certainly dont want to fan the flames of the populist left and that has been their primary enemy since day 1 of the trump Presidency (and before, if you consider how Bernie got marginalized).

2. The russia narrative sustains viewership, and it always has been, as a corporate media understood “nothing burger” in order to fleece viewership ratings from angry americans seeking someone to blame for the loss of Clinton. Liberal americans shocked about Trumps victory want something to blame and scapegoating a hostile foreign nation certainly feeds that desperate search while misdirecting their attention away from the personal failures of the Clinton campaign and the bombshells from the leaks.

3. The affiliation of Black Lives Matter with Russia Hacked The Election™ has the effect of undermining progressive support among liberal and centrist voters, who will now disregard news of police brutality as Fake News Russia Collusion in favour of Trump

What’s more, they will begin to understand Black Lives Matter as an organization produced by Russia and thus, double plus ungood and of course pointing out BLM with now prompt calls of Putin supporting FAKE NEEEeEEEeeEEEeeeeWWWWSSS!!!.

4. The narrative building up Russia as a super genius, ultimate evil that has infiltrated american society and the minds of it’s unruly youth and uppity minorities is cemented in the minds of baby boomers. The illusion of Putin as this super genius movie villain serves the enduring American hegemonic goal of destroying russia by preparing the American public for war, you see, because Russia is already at war with America, and thus it must be stopped. They have infiltrated pokemon go, by god. What’s next? Mind control rays?! This is McCarthyism at its FINEST my dudes.

Why the left isnt losing their fucking minds and pointing out the obvious nature of this psyop against the mostly democrat viewership of nighttime newcasts like CNN is beyond me.

But true progressives always lose, because they cant think around this shit in a lateral way. Progressive activism functions like constantly charging at the door with a nazi symbol crudely drawn on it, hoping continued, unrelenting brute strength wins the day as they get get outmaneuvered by their liberal “allies” and the right wing who exploit their bullheadedness.

[mikemortgage]

Generex Biotechnology Receives IND Approval from FDA for Phase II Combination Study using AE37 plus Keytruda® (pembrolizumab) for the Treatment of Triple Negative Breast Cancer

MIRAMAR, Fla. — Generex Biotechnology Corporation (OTCQB:GNBT) today announced that the FDA had reviewed the company’s investigational new drug (IND) application and given notification that the study can proceed. The study: A Phase II Clinical Trial of Pembrolizumab (Keytruda®) in Combination with the AE37 Peptide Vaccine in Patients with Metastatic Triple Negative Breast Cancer, is sponsored by Generex and conducted under a collaboration agreement with Merck and a clinical trial agreement with the NSABP Foundation, Inc. (NSABP).

The combination study builds on previous clinical studies of both AE37 and Keytruda®. AE37, a cancer vaccine, was the subject of a 300 patient prospective, randomized and single-blinded Phase II study in patients with breast cancer. That study showed a strong trend toward reduced relapses,particularly in patients with triple negative breast cancer. Keytruda® also has shown encouraging results in patients with triple negative breast cancer when used as monotherapy. The complementary mechanisms of action of the two drugs suggest the combination may have the potential to be better than either alone.

AE37 is unique among therapeutic cancer vaccines in that it ensures specific activation of CD4+ T helper cells, which are critical in generating an effective immune response. Its improved immunological potency, along with an excellent safety profile, offers particular advantages for combination studies. In addition to the Phase II study in breast cancer patients, AE37 also has been tested in a Phase I study in prostate cancer patients. AE37 treated patients have consistently displayed a robust, long-lasting and specific response to the vaccine.

Liesha Emens, M.D., Ph.D., Principal Investigator for the study and Professor of Medicine at the University of Pittsburgh Medical Center commented: “So far, metastatic triple negative breast cancer patients treated upfront with immunotherapy benefit clinically from immune checkpoint immunotherapy only if their tumors contain PDL1+ cells. Increasing the number of patients with immune-activated tumors should bring the benefit of immunotherapy to even more patients. This Phase II trial will test whether the AE37 vaccine may trigger immunity in triple negative breast cancer patients, priming them for clinical benefit from immune checkpoint blockade.”

Eric von Hofe, President of NuGenerex-ImmunoOncology commented: “We are gratified to see this important trial moving forward. While we have tested AE37 in breast and prostate cancer patients, there is good rationale for inclusion of AE37 in the treatment regimen of a variety of additional cancer types of high unmet need. Gastric, colon, ovarian and bladder cancers all express the same tumor target expressed in breast and prostate cancer that AE37 activates the immune system to recognize.”

About AE37

AE37 is an investigational therapeutic cancer vaccine being developed to treat certain types of breast cancer. It is a combination of portions of two proteins that together stimulate the immune system to fight cancer cells.

Up to 80 percent of breast cancers express some level of a protein called HER2. While treatments exist to target HER2 in breast cancer patients with the highest level of HER2 expression (roughly 25%), the majority of patients who have lower levels of expression have more limited treatment options. AE37 consists of a protein derived from the HER2 protein combined with a portion of the MHC class II associated invariant chain which has been termed Ii-Key.

AE37 does not directly target HER2, but rather acts as a vaccine to activate the immune system to recognize the HER2 protein, which is expressed on cancer cells as foreign. AE37 ensures activation of CD4-positive lymphocytes, immune cells that are important in stimulating both the antibody response (antibodies against HER2) and cellular responses directed against the HER2 protein in breast cancer cells. The Ii-Key peptide is coupled with the HER2 protein to ensure a more robust and long-lasting response.

About Generex Biotechnology

Generex is a strategic, diversified healthcare holdings company with offerings in a variety of arenas, including diagnostics, medical devices, and pharmaceutical development. The Company’s direct-to-patient services support its strategy of all-inclusive access to doctors, diagnostics, therapeutics, and additional health-related services to greatly improve the patient experience in receiving care. On the provider side, Generex’s management services remove administrative burdens in multiple provider settings, including private practice and hospital, allowing doctors to devote more time to patient care. Revenue from the Company’s subsidiaries supports the clinical advancement of its wholly owned therapeutic products with a focus in immunotherapeutics based on stimulating critical members of the immune response, known as T helper cells, and in its proprietary buccal administration of insulin.

Cautionary Note Regarding Forward-Looking Statements

This release and oral statements made from time to time by Generex representatives in respect of the same subject matter may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by introductory words such as “expects,” “plan,” “believes,” “will,” “achieve,” “anticipate,” “would,” “should,” “subject to” or words of similar meaning, and by the fact that they do not relate strictly to historical or current facts. Forward-looking statements frequently are used in discussing potential product applications, potential collaborations, product development activities, clinical studies, regulatory submissions and approvals, and similar operating matters. Many factors may cause actual results to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known and others of which are not. Known risks and uncertainties include those identified from time to time in the reports filed by Generex with the Securities and Exchange Commission, which should be considered together with any forward-looking statement. No forward-looking statement is a guarantee of future results or events, and one should avoid placing undue reliance on such statements. Generex undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise. Generex claims the protection of the safe harbor for forward-looking statements that is contained in the Private Securities Litigation Reform Act.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181212005519/en/

Contacts

Generex Biotechnology Corporation

Joseph Moscato 646-599-6222

Todd Falls 800-391-6755 Extension 222

investor@generex.com

Russo Partners

Investor / Media Contacts:

Alex Fudukidis (646) 942-5632 alex.fudukidis@russopartnersllc.com

Caroline Cunningham (212) 845-4292 Caroline.Cunningham@russopartnersllc.com

from Financial Post https://ift.tt/2PyuaIo via IFTTT Blogger Mortgage Tumblr Mortgage Evernote Mortgage Wordpress Mortgage href="https://www.diigo.com/user/gelsi11">Diigo Mortgage

[mikemortgage]

Ferring and Evotec Form Strategic Research Alliance in Reproductive Medicine and Women’s Health

SAINT-PREX, Switzerland & HAMBURG, Germany — Ferring Pharmaceuticals and Evotec AG (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) today announced a strategic research alliance to discover and develop new small molecule therapies to treat patients living with fertility and gynaecological conditions.

Evotec will apply its drug discovery platform to design novel and efficacious treatments in partnership with Ferring. The multi-target, multi-year collaboration aims to deliver small molecule pre-clinical development (PDC) and investigational new drug (IND) ready candidates. As part of the alliance, Evotec is eligible for undisclosed research funding and milestones.

“To achieve leadership in reproductive medicine and women’s health, we are expanding beyond our historical expertise in peptides and tackling molecular targets that are best addressed using small molecule therapeutics,” said Per Falk, Chief Science Officer, Ferring Pharmaceuticals. “Evotec is a highly regarded company in this field, and this alliance offers the prospect of significant innovation for patients. Together, we have the potential to make a difference for both men and women who are struggling to start a family, and for women suffering from gynaecological conditions.”

“The integration of our industry-leading small molecule discovery and development platform with Ferring’s expertise in reproductive medicine and women’s health will create a powerful combination that we hope will create a difference for patients suffering from fertility and gynaecological conditions. We very much look forward to working with such an innovative partner,” commented Dr Mario Polywka, Chief Operating Officer of Evotec.

About Ferring Pharmaceuticals Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. Headquartered in Saint-Prex, Switzerland, Ferring is a leader in reproductive medicine and women’s health, and in specialty areas within gastroenterology and urology. Ferring has been developing treatments for mothers and babies for over 50 years. Today, over one third of the company’s research and development investment goes towards finding innovative and personalised healthcare solutions to help mothers and babies, from conception to birth. Founded in 1950, Ferring now employs approximately 6,500 people worldwide, has its own operating subsidiaries in nearly 60 countries and markets its products in 110 countries.

Learn more at www.ferring.com, or connect with us on Twitter, Facebook, Instagram, LinkedIn and YouTube.

About Evotec AG Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists. We operate worldwide and our more than 2,400 employees provide the highest quality stand-alone and integrated drug discovery and development solutions. We cover all activities from target-to-clinic to meet the industry’s need for innovation and efficiency in drug discovery and development (EVT Execute). The Company has established a unique position by assembling top-class scientific experts and integrating state-of-the-art technologies as well as substantial experience and expertise in key therapeutic areas including neuronal diseases, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. On this basis, Evotec has built a broad and deep pipeline of approx. 100 co-owned product opportunities at clinical, pre-clinical and discovery stages (EVT Innovate). Evotec has established multiple long-term alliances with partners including Bayer, Boehringer Ingelheim, Celgene, CHDI, Novartis, Novo Nordisk, Pfizer, Sanofi, Takeda, UCB and others.

For additional information please go to www.evotec.com and follow us on Twitter @EvotecAG.

Forward looking statements Information set forth in this press release contains forward-looking statements, which involve a number of risks and uncertainties. The forward-looking statements contained herein represent the judgement of Evotec as of the date of this press release. Such forward-looking statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond our control, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based.

# # #

Contacts

Ferring Pharmaceuticals Bhavin Vaid Head of Corporate Communications +41 58 301 0952 (direct) +41 79 191 0632 (mobile) bhavin.vaid@ferring.com or Lindsey Rodger Senior Manager, Corporate Communications +41 58 451 4023 (direct) +41 79 191 0486 (mobile) lindsey.rodger@ferring.com or Gabriele Hansen VP Corporate Communications & Investor Relations T. +49 (0)40 560 81 255 F. +49 (0)40 560 81 333 gabriele.hansen@evotec.com

from Financial Post https://ift.tt/2yoc324 via IFTTT Blogger Mortgage Tumblr Mortgage Evernote Mortgage Wordpress Mortgage href="https://www.diigo.com/user/gelsi11">Diigo Mortgage